# High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)

> **NCT05587673** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 3 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Crohn Disease
- Ulcerative Colitis
- Indeterminate Colitis

## Interventions

- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT05587673
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-06
- **Primary completion:** 2023-10-11
- **Final completion:** 2024-10-11
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2024-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05587673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05587673, "High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05587673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*